Abbott Laboratories (ABT) Stock Forecast & Price Target
Score
Abbott Laboratories price target
| ABT | |
|---|---|
| Low | $112.00 |
| Average | $121.36 |
| High | $130.00 |
| Upside vs current price | +11.8% |
The average target of $121.36 is +11.8% versus the current ABT price of $108.52.
Abbott Laboratories analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 5 |
| Buy | 18 |
| Hold | 5 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
28 analysts cover ABT.
Abbott Laboratories EPS and revenue estimates
Published annual figures for ABT on this page are 2026 EPS $5.52, 2027 EPS $5.93. Coverage under three analysts is omitted.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $5.52 | $49.99B |
| 2027 | $5.93 | $53.68B |
Is Abbott Laboratories a buy or sell?
Of the 28 analysts covering Abbott Laboratories, 23 rate it a buy (5 strong buy and 18 buy), 5 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The ABT consensus label is Buy, beside 23 buy-side ratings and 0 sell-side ratings.
The average target of $121.36 implies +11.8% versus the current price of $108.52.
The ABT rating block is 28 published views with a Buy label. It does not tell you whether to buy or sell.
Reading the Abbott Laboratories forecast
the Abbott Laboratories has a tight target cluster: $112.00 to $130.00, average $121.36.
The gap from the $108.52 price to the ABT average is +11.8%.
The ABT rating mix is lopsided rather than split: 23 of 28 analysts are on the buy side, 5 are at hold, and 0 are on the sell side, and the published consensus is Buy.
the Abbott Laboratories has seen more upgrades (2) than downgrades (1) lately.
ABT targets have not moved much: $121.00 recently, $122.67 across the quarter.
the Abbott Laboratories is followed by 28 analysts, so the range matters more than any one target.
Abbott Laboratories forecast questions
What is the ABT price target?
The published range for ABT is $112.00 to $130.00, with an average of $121.36. That average is +11.8% versus the current price of $108.52.
Is Abbott Laboratories a buy or sell?
Of the 28 analysts covering Abbott Laboratories, 23 rate it a buy, 5 rate it a hold, and 0 rate it a sell. The consensus is Buy, leaving ABT at 23 buy ratings, 5 holds, and 0 sells.
What is the EPS estimate for Abbott Laboratories?
Analyst EPS estimates for Abbott Laboratories: 2026 $5.52, 2027 $5.93.
What is the revenue estimate for Abbott Laboratories?
Analyst revenue estimates for Abbott Laboratories: 2026 $49.99B, 2027 $53.68B.
How many analysts cover ABT?
28 analysts cover ABT. Their consensus on ABT is Buy, across those 28.